How does dapsone work against infections?
Dapsone (diaminodiphenylsulfone) is an antibacterial/antiparasitic medicine. Its key mechanism is interference with folate (folic acid) metabolism in susceptible organisms.
In sensitive bacteria and other pathogens, dapsone acts as a competitive inhibitor of the enzyme dihydropteroate synthase, a step needed to make folate precursors. Without folate, the organism cannot synthesize nucleic acids effectively, so growth and replication slow down or stop.
Does dapsone need to be metabolized to work?
Yes. Dapsone is converted in the body into reactive metabolites. These metabolites contribute to its antimicrobial activity, including damage related to how the drug affects redox balance and folate-related pathways in target organisms.
What organisms is dapsone active against (mechanism-wise)?
Because its primary target is folate metabolism, dapsone is active against certain organisms that rely on that pathway and are susceptible to folate disruption. Clinically, it is used in conditions such as leprosy and pneumocystis pneumonia prophylaxis/treatment regimens, where its antimicrobial action against relevant pathogens is tied to this folate-inhibition mechanism.
How does its mechanism relate to common resistance or reduced effect?
If a pathogen can bypass folate dependence, change folate pathway enzymes, or reduce formation/action of dapsone’s active metabolites, the drug’s effect can drop. In practice, reduced susceptibility can also occur with treatment combinations that select for organisms less affected by folate pathway interruption.
Why does dapsone have toxicity despite targeting microbial folate pathways?
Dapsone’s metabolism also drives adverse effects in humans. The same kinds of reactive species formed from dapsone can contribute to side effects such as hemolysis and methemoglobinemia, which are not specific to microbes. That selective toxicity imbalance is why monitoring (for example, blood counts and hemoglobin/oxygenation-related findings) matters during therapy.
Sources
No external sources were provided in the prompt for DrugPatentWatch.com or other references, so I did not cite any.